Literature DB >> 28294633

Platelet Count and Mean Platelet Volume at the Time of and After Acute Myocardial Infarction.

Alok Ravindra Amraotkar1, David Day Song2, Diana Otero3, Patrick James Trainor1,4, Imtiaz Ismail5, Vallari Kothari6, Ayesha Singh2, Joseph B Moore1, Shesh Nath Rai5,7, Andrew Paul DeFilippis1,8,9.   

Abstract

Platelet count has been shown to be lower and mean platelet volume (MPV) to be higher in acute myocardial infarction (MI). However, it is not known whether these changes persist post-MI or if these measures are able to distinguish between acute thrombotic and non-thrombotic MI. Platelet count and MPV were measured in 80 subjects with acute MI (thrombotic and non-thrombotic) and stable coronary artery disease (CAD) at cardiac catheterization (acute phase) and at >3-month follow-up (quiescent phase). Subjects were stratified using stringent clinical, biochemical, histological, and angiographic criteria. Outcome measures were compared between groups by analysis of variance. Forty-seven subjects met criteria for acute MI with clearly defined thrombotic (n = 22) and non-thrombotic (n = 12) subsets. Fourteen subjects met criteria for stable CAD. No significant difference was observed in platelet count between subjects with acute MI and stable CAD at the acute or quiescent phase. MPV was higher in acute MI (9.18 ± 1.21) compared to stable CAD (8.13 ± 0.66; P = 0.003) at the acute phase but not at the quiescent phase (8.48 ± 0.58 vs 8.94 ± 1.42; P = 0.19). No difference in platelet count or MPV was detected between thrombotic and non-thrombotic subsets at acute or quiescent phases. The power to detect differences in these measures between thrombotic and non-thrombotic subsets was 58%. Higher MPV at the time of acute MI is not observed by 3 months post-MI (quiescent phase). Platelet count and MPV do not differ in subjects with thrombotic versus non-thrombotic MI. Further investigation is warranted to evaluate the utility of these measures in the diagnosis of acute MI.

Entities:  

Keywords:  acute coronary syndrome; atherothrombosis; platelet activation; vascular physiology

Mesh:

Year:  2016        PMID: 28294633      PMCID: PMC5572529          DOI: 10.1177/1076029616683804

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  39 in total

Review 1.  Platelets in atherothrombosis.

Authors:  Zaverio M Ruggeri
Journal:  Nat Med       Date:  2002-11       Impact factor: 53.440

2.  Angiographic correlates in type 1 and 2 MI by the universal definition.

Authors:  John A Ambrose; Andreia Loures-Vale; Usman Javed; Cyrus F Buhari; Waqas Aftab
Journal:  JACC Cardiovasc Imaging       Date:  2012-04

3.  Increased mean platelet volume in patients with acute coronary syndromes.

Authors:  Giuseppe Lippi; Luca Filippozzi; Gian Luca Salvagno; Martina Montagnana; Massimo Franchini; Gian Cesare Guidi; Giovanni Targher
Journal:  Arch Pathol Lab Med       Date:  2009-09       Impact factor: 5.534

4.  Third universal definition of myocardial infarction.

Authors:  Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Maarten L Simoons; Bernard R Chaitman; Harvey D White
Journal:  Glob Heart       Date:  2012-09-26

5.  Diagnostic importance of admission platelet volume indices in patients with acute chest pain suggesting acute coronary syndrome.

Authors:  Mohammad Reza Dehghani; Leila Taghipour-Sani; Yousef Rezaei; Rahim Rostami
Journal:  Indian Heart J       Date:  2014-11-10

6.  ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation task force on Clinical Expert Consensus Documents.

Authors:  L Kristin Newby; Robert L Jesse; Joseph D Babb; Robert H Christenson; Thomas M De Fer; George A Diamond; Francis M Fesmire; Stephen A Geraci; Bernard J Gersh; Greg C Larsen; Sanjay Kaul; Charles R McKay; George J Philippides; William S Weintraub
Journal:  J Am Coll Cardiol       Date:  2012-11-12       Impact factor: 24.094

7.  Circulating levels of plasminogen and oxidized phospholipids bound to plasminogen distinguish between atherothrombotic and non-atherothrombotic myocardial infarction.

Authors:  Andrew P DeFilippis; Ilya Chernyavskiy; Alok R Amraotkar; Patrick J Trainor; Shalin Kothari; Imtiaz Ismail; Charles W Hargis; Frederick K Korley; Gregor Leibundgut; Sotirios Tsimikas; Shesh N Rai; Aruni Bhatnagar
Journal:  J Thromb Thrombolysis       Date:  2016-07       Impact factor: 2.300

Review 8.  Thrombopoietin: the primary regulator of platelet production.

Authors:  K Kaushansky
Journal:  Blood       Date:  1995-07-15       Impact factor: 22.113

9.  Mean platelet volume as an indicator of platelet activation: methodological issues.

Authors:  Yongsoon Park; Norberta Schoene; William Harris
Journal:  Platelets       Date:  2002 Aug-Sep       Impact factor: 3.862

10.  Mean platelet volume and other platelet volume indices in patients with stable coronary artery disease and acute myocardial infarction: A case control study.

Authors:  Vitthal Khode; Jayaraj Sindhur; Deepak Kanbur; Komal Ruikar; Shobha Nallulwar
Journal:  J Cardiovasc Dis Res       Date:  2012-10
View more
  8 in total

1.  Change in matrix metalloproteinase 2, 3, and 9 levels at the time of and after acute atherothrombotic myocardial infarction.

Authors:  Ugochukwu Shola Owolabi; Alok Ravindra Amraotkar; Amanda R Coulter; Narayana Sarma V Singam; Bahjat N Aladili; Ayesha Singh; Patrick James Trainor; Riten Mitra; Andrew Paul DeFilippis
Journal:  J Thromb Thrombolysis       Date:  2020-02       Impact factor: 5.221

Review 2.  Platelets Are at the Nexus of Vascular Diseases.

Authors:  Héloïse Lebas; Katia Yahiaoui; Raphaël Martos; Yacine Boulaftali
Journal:  Front Cardiovasc Med       Date:  2019-09-11

3.  Systemic Immune-Inflammatory Index Predicts Clinical Outcomes for Elderly Patients with Acute Myocardial Infarction Receiving Percutaneous Coronary Intervention.

Authors:  Jiabao Huang; Qing Zhang; Runchang Wang; Hongyan Ji; Yusi Chen; Xiaoqing Quan; Cuntai Zhang
Journal:  Med Sci Monit       Date:  2019-12-18

Review 4.  Emerging Role of Platelet-Endothelium Interactions in the Pathogenesis of Severe SARS-CoV-2 Infection-Associated Myocardial Injury.

Authors:  Theresa M Rossouw; Ronald Anderson; Pravin Manga; Charles Feldman
Journal:  Front Immunol       Date:  2022-02-04       Impact factor: 7.561

Review 5.  From Classic to Modern Prognostic Biomarkers in Patients with Acute Myocardial Infarction.

Authors:  Cristian Stătescu; Larisa Anghel; Bogdan-Sorin Tudurachi; Andreea Leonte; Laura-Cătălina Benchea; Radu-Andy Sascău
Journal:  Int J Mol Sci       Date:  2022-08-15       Impact factor: 6.208

6.  Are Platelet Indices such as Platelet Volume, Platelet Distribution Width, and Plateletcrit Associated with Peyronie Disease?

Authors:  Suleyman Sami Cakir; Sait Ozbir; Hasan Anıl Atalay; Mehmet Gokhan Culha; Osman Can; Halil Lütfi Canat
Journal:  World J Mens Health       Date:  2019-06-26       Impact factor: 5.400

7.  Predictive Value of Hematologic Indices in the Diagnosis of Acute Coronary Syndrome.

Authors:  Kevin Luke; Bambang Purwanto; Lilik Herawati; Makhyan Jibril Al-Farabi; Yudi Her Oktaviono
Journal:  Open Access Maced J Med Sci       Date:  2019-08-13

Review 8.  Antiplatelet Therapy with Integrated Traditional Chinese and Western Medicine for Use in Myocardial Ischemia-Reperfusion Injury: A Review of Clinical Applications and Mechanisms.

Authors:  Yuxuan Li; Yan Li; Bin Li; Yang Liu; Jingqian Zhang; Wu Kuang; Jinjin Lu; Zheng Cao; Jie Cui; Zongjing Fan; Bin Guo; Dong Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-20       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.